Commission Regulation (EC) No 2703/94 of 7 November 1994 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance) (c. 2703)

ANNEX U.K.

A.

Annex I is amended as follows:

1.

Anti-infectious agents

1.2.

Antibiotics

1.2.5.

Florfenicol and related compounds

Pharmacologically active substances	Marker residue	Animal species	MRLs	Target tissues	Other provisions
‘1.2.5.1. Florfenicol	Sum of florfenicol and its metabolites measured as florfenicol-amine	Bovine	200 μg/kg 300 μg/kg 3 000 μg/kg	Muscle Kidney Liver’

B.

In Annex II, point 2. ‘Organic compounds’ the following headings are added:

2.

Organic compounds

Pharmacologically active substance(s)	Animal species	Other provisions
‘2.9. Gonadotrophin releasing hormone	All food producing species’

C.

Annex III is amended as follows:

1.

Anti-infectious agents

2.

Antibiotics

1.2.4.

Cephalosporins

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
‘1.2.4.1. Ceftiofur	Sum of all residues retaining the betalactam structure expressed as desfuroyleceftiofur	Bovine	2 000 μg/kg 200 μg/kg 600 μg/kg 100 μg/kg	Kidney, liver Muscle Fat Milk	Provisional MRLs expire on 1 July 1997’
		Porcine	4 000 μg/kg 3 000 μg/kg 500 μg/kg 600 μg/kg	Kidney Liver Muscle Fat

2.

Antiparasitic agents

2.3.

Agents acting against endo- and ectoparasites

2.3.1.

Avermectins

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
‘ 2.3.1.1. Moxidectin	Moxidectin	Bovine	200 μg/kg	Fat	Provisional MRLs expire on 1 July 1997’
Ovine	20 μg/kg	Kidney, liver